AGA Nanotech and UCL Business Reach Milestone Licensing Agreement for TIPS Microparticle Technology

AGA Nanotech Ltd is pleased to announce the successful conclusion of a licensing agreement with UCL Business for the use of Thermally Induced Phase Separation (TIPS) microparticle technology, which enables the controlled delivery of antimicrobial agents in healthcare settings. The agreement is the result of a collaborative translational research program supported by the UCL Translational Research Office, the University College London Hospitals Biomedical Research Centre (BRC), and AGA Nanotech.

AGA Nanotech’s collaboration with UCL is key to furthering our goal to develop non-antibiotic antimicrobial solutions. “The collaboration with Dr. Day’s group has been highly productive, enabling us to test innovative ideas that open new business opportunities. By combining the TIPS delivery system with our proprietary antimicrobials, we believe we can offer unique alternative to conventional antibiotics, not only in human healthcare but also in animal healthcare.